Offering much needed relief for Woodford-associated funds, sequencing unicorn Oxford Nanopore raises $105.9M in new cash
Investors in Oxford Nanopore Technologies — including Neil Woodford’s former fund — has managed to recoup some cash as the gene sequencing device maker closes its latest round and, in the process, boosts its unicorn valuation.
The company said it’s brought in $38.6 million (£29.3 million) in new capital and helped some backers find new firms to take their stake, leading to a secondary sale totaling $105.9 million (£80.2 million). All told, the $144.5 million (£109.5 million) financing upped its valuation to over $2 billion, the Times reported.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.